Biocon board approves sale of branded formulations business to subsidiary
The Board of Directors in its meeting approved the sale of Branded Formulations India (BFI) business to Biocon Biologics India (BBIL). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 17, 2019 Category: Pharmaceuticals Source Type: news

In nationwide call, doctors put OPDs and surgeries on hold
OPDs at AIIMS and Safdarjung Hospital, where over 10,000 patients come daily, will remain shut too. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 14, 2019 Category: Pharmaceuticals Source Type: news

New psoriasis drug study yields positive results: Dr Reddy's
According to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in future dermatology conferences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 10, 2019 Category: Pharmaceuticals Source Type: news

World needs generic drugs but their quality must be guaranteed: Journalist Katherine Eban
Eban discusses her findings and how regulators and countries need to step up to protect patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 8, 2019 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma says co, subsidiary made party to litigation proceeding in US
The drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless allegations' against the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 7, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for Parkinson's disease treatment drugs
Quoting IQVIA sales data, the company said the two products had an estimated market size of USD 24 million for 12 months ended December 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 6, 2019 Category: Pharmaceuticals Source Type: news

AstraZeneca's blood cancer drug meets main goal in late-stage trial
The drug, Calquence, showed meaningful improvement in patients with lymphocytic leukaemia when compared with a chemotherapy-based treatment, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 6, 2019 Category: Pharmaceuticals Source Type: news

USFDA issues 9 observations to Natco Pharma's Kothur facility
"At the end of the inspection, the facility received 9 observations, with no repeat observations and mostly procedural in nature," Natco Pharma said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 6, 2019 Category: Pharmaceuticals Source Type: news

Dhanuka Laboratories leads race for Orchid Pharma
Besides Dhanuka, two other companies - Accord Life Spec and Covalent Laboratories - had bid for Chennai-based Orchid Pharma in a second round of bidding, (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 5, 2019 Category: Pharmaceuticals Source Type: news

Two-thirds of AIDS treatment drugs supplied globally by India
"These affordable generic medicines have helped scale up access to treatment across developing countries," Paulomi Tripathi, a First Secretary in India's UN mission, told the General Assembly on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 4, 2019 Category: Pharmaceuticals Source Type: news

70 products in pipeline,Dr Reddy's bullish on China
A top Commerce Department official recently said India pressed China to import more Indian goods, especially pharmaceutical and IT products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 2, 2019 Category: Pharmaceuticals Source Type: news

Natco, Onyx settle cancer drug patent litigation
The Indian generic drug maker had partnered with Breckenridge Pharmaceutical for marketing its Carfilzomib injection in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 31, 2019 Category: Pharmaceuticals Source Type: news

Lupin's Goa facility may face regulatory action, says USFDA
The USFDA has stated that it may withhold approval of any pending applications or supplements in which this facility is listed," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 30, 2019 Category: Pharmaceuticals Source Type: news

Addressable market for e-pharmacies in India to reach $18.1 bn by 2023: EY
Besides, the increase in chronic diseases, rising per capita income and resultant healthcare spend will also aid to its growth. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 29, 2019 Category: Pharmaceuticals Source Type: news

JB Chemicals promoters to offload 57% stake
PE and pharma peers have been sounded out and a formal process is due to be launched, said sources. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 28, 2019 Category: Pharmaceuticals Source Type: news

Manipal Hospitals to buy Medanta in Rs 5,800 crore deal
Medanta, founded in 2009, operates super speciality hospitals and clinics. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 26, 2019 Category: Pharmaceuticals Source Type: news

CCI approves GSK, Pfizer consumer healthcare JV formation
After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 24, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for overactive bladder treatment drug
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 21, 2019 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo vs Singh Brothers: How a diary note made the difference
The revelation of the "journal" is part of a controversial book Bottle of Lies released recently. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 20, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's to spend upto $ 300 million on R & D in FY 20
The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the sales for the quarter, he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 20, 2019 Category: Pharmaceuticals Source Type: news

Pharma companies can ’t sell tweaked drugs under old brand name
The issue has been discussed for years now, and was deliberated in several Drugs Consultative Committee meetings held since 2008. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 17, 2019 Category: Pharmaceuticals Source Type: news

Ex-FDA chief Scott Gottlieb endorses use of generic drugs
Gottlieb, 46, who resigned in the middle of his tenure in March this year, has been tweeting to convince patients that generic drugs are safe. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 16, 2019 Category: Pharmaceuticals Source Type: news

Swarms of bugs, missing data plague firms now making heart drug
Last month, the FDA posted a list of 43 versions of valsartan and similar drugs that don ’t contain carcinogens. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 16, 2019 Category: Pharmaceuticals Source Type: news

FDA urged to crack down on European firms shipping abortion pills to US from India
The letter urges Sharpless to take action to stop the illegal practices of Aid Access and other mail-order abortion providers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 15, 2019 Category: Pharmaceuticals Source Type: news

Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price rigging
The lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2019 Category: Pharmaceuticals Source Type: news

US states file 2nd lawsuit accusing Aurobindo Pharma, others firms for violating antitrust laws
Aurobindo Pharma said "we expect that we will be filing papers with the Federal Court in due course denying each of the relevant accusations". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2019 Category: Pharmaceuticals Source Type: news

Zydus Pharmaceuticals Inc among cos facing lawsuit by US states: Cadila
In a regulatory filing, Cadila said in its opinion this particular matter is not likely to have any material impact on the operations and financials of the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 14, 2019 Category: Pharmaceuticals Source Type: news

NCLT refers Sterling Biotech for liquidation
“The tribunal has decided to refer the company for insolvency in a verbal order,” said one of the people. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 10, 2019 Category: Pharmaceuticals Source Type: news

Lupin launches generic seizure drug in US
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug Administration (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 10, 2019 Category: Pharmaceuticals Source Type: news

Lupin gets more time from govt to complete project in Indore SEZ
The company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations metered dose inhalers and dry powder inhalers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 8, 2019 Category: Pharmaceuticals Source Type: news

Abbott anti-profiteering case stayed, hope for other firms
Experts say this could prompt firms to seek a stay on anti-profiteering proceedings till the time the issue surrounding constitutional validity is settled by high courts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 8, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic testosterone gel in US market
The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved USFDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 6, 2019 Category: Pharmaceuticals Source Type: news

Sun Pharmaceuticals to set up an ethics committee to oversee corporate governance-related matters
Sudhir Valia to focus more on pursuits outside Sun, but continues to be a valuable resource for the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 6, 2019 Category: Pharmaceuticals Source Type: news

Lupin, Zydus Pharmaceuticals recall products in the US
Zydus Pharmaceuticals USA Inc, a subsidiary of Zydus Cadila, is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high blood pressure, in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2019 Category: Pharmaceuticals Source Type: news

China's war on healthcare costs lures India's biggest drugmaker
Shanghvi believes market watchers are underestimating the potential in China for India ’s largest drugmaker. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2019 Category: Pharmaceuticals Source Type: news

Cipla is undergoing a big transformation and is doing something it once eschewed
A difficult transformation is underway at Cipla, one of India ’s largest and oldest pharma companies, as it grapples with a generational shift and embraces a market it had eschewed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2019 Category: Pharmaceuticals Source Type: news

What we had done for India, we are now doing for US: Umang Vohra, MD, Cipla
In an interview with Suman Layak, Vohra explains his strategy of taking Cipla products to global markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2019 Category: Pharmaceuticals Source Type: news

We see faster and significant growth in US: Samina Vaziralli, executive vice-chairperson, Cipla
As executive vice-chairperson of Cipla, Samina Vaziralli represents the third generation from the promoter ’s family involved in its management. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2019 Category: Pharmaceuticals Source Type: news

Substandard drugs are a bigger problem for India than fakes
A review of the annual reports of the country ’s top 10 pharma companies shows that words like “counterfeit”, “spurious" or “fake” drugs do not find any mention. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2019 Category: Pharmaceuticals Source Type: news

Pharma may see a price war in good news for diabetics
Glenmark launches a drug at almost half the price of those offered by rivals. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2019 Category: Pharmaceuticals Source Type: news

USFDA makes 'certain' observations for Torrent Pharma's Indrad plant
The audit at Indrad plant of the company was carried out by the United States Food and Drug Administration (USFDA) in April. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 26, 2019 Category: Pharmaceuticals Source Type: news

USFDA retains OAI status for Indoco's Goa plant
The facility was inspected by the USFDA in January 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 24, 2019 Category: Pharmaceuticals Source Type: news

Novartis picks Sanjay Murdeshwar of AstraZeneca to lead its India business
Murdeshwar according to his current LinkedIn profile is the Global Vice President, Cardio-Renal business at Astrazeneca. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Cipla appoints Dr Raju Mistry as global chief people officer
Mistry is a veteran Human Resources (HR) professional with over 27 years of global experience across diverse sectors. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets USFDA nod for 2 generic products
The product is generic version of Sanofi-Aventis US LLC's Aubagio tablets in the same strengths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from US
The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 21, 2019 Category: Pharmaceuticals Source Type: news

Lupin seeks more time from commerce ministry to complete Indore SEZ project
Company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhalers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2019 Category: Pharmaceuticals Source Type: news

Granules India gets USFDA nod for pain relief drug
The approved product is bioequivalent to the reference listed drug product (RLD), Tylenol tablets, extended release. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2019 Category: Pharmaceuticals Source Type: news

Hair in one vail, Aurobindo recalls 88k Lidocaine injections from US
According to a notification put up by the US Drug regulator in its website, these vials were manufactured in India for AuroMedics Pharna LLC. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2019 Category: Pharmaceuticals Source Type: news

Many essential drugs priced much higher than manufacturing cost: WHO
Even off patent drugs which are in the market for long and commonly used for diseases like HIV, tuberculosis and malaria are priced very high. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2019 Category: Pharmaceuticals Source Type: news